Product
GnRH
Aliases
gonadotropin-releasing hormone
17 clinical trials
29 indications
Indication
Delayed PubertyIndication
Kallmann SyndromeIndication
hypogonadotropic hypogonadismIndication
GnRH DeficiencyIndication
hyperprolactinemiaIndication
HypogonadismIndication
Reproductive DisorderIndication
Polycystic Ovary SyndromeIndication
Down syndromeIndication
Mild Cognitive ImpairmentIndication
Alzheimer's diseaseIndication
Early OnsetIndication
Olfactory DysfunctionIndication
Prostate CancerIndication
Polycystic Ovarian SyndromeIndication
Hypothalamic AmenorrheaIndication
Reproductive DisordersIndication
ObesityIndication
infertilityIndication
Hypogonadotropic HypogonadotropismIndication
HyperinsulinemiaIndication
maleIndication
Androgen DeficiencyIndication
Metabolic disorderIndication
Metabolic SyndromeIndication
metabolic disorderIndication
Cardiovascular DiseasesIndication
NAFLDIndication
DiabetesClinical trial
Kisspeptin in the Evaluation of Delayed PubertyStatus: Completed, Estimated PCD: 2019-09-08
Clinical trial
Administration of Kisspeptin in Patients With HyperprolactinemiaStatus: Completed, Estimated PCD: 2023-06-28
Clinical trial
Dampening the Reproductive Axis With Continuous KisspeptinStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
Effect of Pulsatile GnRH Therapy on Cognition in Down Syndrome: Randomized Placebo Control StudyStatus: Recruiting, Estimated PCD: 2028-12-01
Clinical trial
Recall by Genotype: Neuropeptide StimulationStatus: Terminated, Estimated PCD: 2024-05-29
Clinical trial
Kisspeptin Administration Subcutaneously to Patients With Reproductive DisordersStatus: Recruiting, Estimated PCD: 2027-06-30
Clinical trial
Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic HypogonadismStatus: Recruiting, Estimated PCD: 2025-05-31
Clinical trial
ATLAS: A Randomized, Double-blind, Placebo-controlled Phase 3 Study of JNJ-56021927 in Subjects With High-risk, Localized or Locally Advanced Prostate Cancer Receiving Treatment With Primary Radiation TherapyStatus: Active (not recruiting), Estimated PCD: 2026-06-30
Clinical trial
Administration of Kisspeptin to Subjects With Reproductive DisordersStatus: Recruiting, Estimated PCD: 2025-08-01
Clinical trial
Kisspeptin Administration Subcutaneously to Patients With Reproductive DisordersStatus: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
Opioid Antagonism in Individuals Ascertained Through the Partners HealthCare BiobankStatus: , Estimated PCD: 2025-05-31
Clinical trial
Reprometabolic Syndrome Mediates Subfertility in ObesityStatus: Completed, Estimated PCD: 2022-01-11
Clinical trial
Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone Acetate and Apalutamide (ARN-509) for Rising PSA After Radical Prostatectomy With Adverse Features.(FORMULA-509 Trial)Status: Active (not recruiting), Estimated PCD: 2025-04-05
Clinical trial
GnRH for Luteal Support in IVF/ICSI/FET CyclesStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in MenStatus: Not yet recruiting, Estimated PCD: 2024-08-01